Trademark search for:

DERMAL FX

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2007-02-02 — Application filed
2007-02-07 — Application filed
2007-05-22 — Assigned to examiner
2007-05-29 — Final disposition recorded
2007-05-29 — Final disposition recorded
2007-11-29 — Fax received
2008-01-11 — Amendment from applicant entered
2008-01-11 — Assigned to lie
2008-01-11 — Correspondence received in law office
2008-02-06 — Final disposition recorded
2008-02-06 — Final disposition recorded
2008-02-06 — Final disposition recorded
2008-07-28 — Attorney/dom.rep.revoked and/or appointed
2008-07-28 — Teas revoke/app/change addr of atty/dom rep received
2008-07-29 — Office action issued
2008-07-29 — Correspondence received in law office
2008-07-30 — Teas/email correspondence entered
2008-09-04 — Suspension letter written
2008-09-04 — Letter of suspension e-mailed
2008-09-04 — Notification of letter of suspension e-mailed
2009-03-04 — Suspension checked - to attorney for action
2009-03-23 — Report completed suspension check case still suspended
2009-09-23 — Suspension checked - to attorney for action
2009-10-13 — Suspension inquiry written
2009-10-13 — Inquiry to suspension e-mailed
2009-10-13 — Notification of inquiry as to suspension e-mailed
2010-04-01 — Teas response to suspension inquiry received
2010-04-02 — Teas/email correspondence entered
2010-04-02 — Correspondence received in law office
2010-04-19 — Suspension letter written
2010-04-19 — Letter of suspension e-mailed
2010-04-19 — Notification of letter of suspension e-mailed
2010-10-22 — Suspension checked - to attorney for action
2010-11-13 — Suspension inquiry written
2010-11-13 — Inquiry to suspension e-mailed
2010-11-13 — Notification of inquiry as to suspension e-mailed
2011-05-09 — Teas response to suspension inquiry received
2011-05-13 — Teas/email correspondence entered
2011-05-13 — Correspondence received in law office
2011-06-06 — Approved for pub - principal register
2011-06-24 — Assigned to lie
2011-06-24 — Law office publication review completed
2011-08-02 — Published for opposition
2011-08-02 — Official gazette publication confirmation e-mailed
2011-09-27 — Noa e-mailed - sou required from applicant
2012-03-05 — Teas statement of use received
2012-03-05 — Use amendment filed
2012-03-05 — Teas change of correspondence received
2012-03-29 — Case assigned to intent to use paralegal
2012-03-29 — Statement of use processing complete
2012-04-19 — Allowed principal register - sou accepted
2012-04-21 — Law office registration review completed
2012-04-24 — Notice of acceptance of statement of use e-mailed
2012-05-29 — Registered-principal register
2017-05-29 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2019-01-04 — Cancelled sec. 8 (6-yr)
2019-01-04 — Final status recorded

Owner Information

DPM Therapeutics Corporation
Burlington, Ontario CA

DPM Therapeutics Corporation
Burlington CA

Filing Details

Filing Date:
2007-02-02

Status Date:
2019-01-04

Category:
Pharmaceuticals

Filing Year:
2007

DERMAL FX

USPTO Filing History

Owner Information

Correspondent

Filing Details